Skip to main content

Caplin Point Laboratories Limited (CAPLIPOINT.NS)

National Stock Exchange of India Healthcare Drug Manufacturers - Specialty & GenericView data quality →
61.6Fair

ValueMarkers Composite Index

Top 84%#7,281 of 44,707
Undervalued

64% below intrinsic value ($56)

UndervaluedFair ValueOvervalued
Piotroski
4/9
Neutral
Beneish
-2.14
Investigate
Altman
27.42
Safe
DCF Value
$56
Undervalued
ROIC
20.2%
Strong
P/E
20.9
Fair
Updated: ·Source: Data sourced from SEC filings and institutional providers. Not financial advice.·Report data issue

Caplin Point Laboratories Limited (CAPLIPOINT.NS) — VMCI valuation read

Caplin Point Laboratories Limited (CAPLIPOINT.NS) carries a VMCI composite of 62/100, 12 points above the Healthcare sector median of 50. Among mid-cap names, that gap places CAPLIPOINT.NS in the top third on the five-pillar weighting (Value 35%, Quality 30%, Integrity 15%, Growth 12%, Risk 8%).

The CAPLIPOINT.NS insider tape has been silent for the past 30 days on Form 4. Where executives neither buy nor sell, the bull and bear cases lean harder on filings cadence and the next earnings line.

**Investor frame.** Value reads CAPLIPOINT.NS trades at 14.0x earnings, 22% below the Healthcare median of 18.0x, which compresses or extends through the 11.0x EV/EBITDA versus a Healthcare 12.0x. Quality: ROIC of 10.0% sits 0.0pp above the Healthcare median (10.0%). Risk: net debt to EBITDA of 2.5x is the rate-sensitivity line to watch, the line to track on Caplin Point Laboratories Limited's next 10-Q.

CAPLIPOINT.NS fell 3.5% over the trailing 7 days, with a -15.3% read on a 30-day basis.

Caplin Point Laboratories Limited develops, produces, markets, and exports generic pharmaceutical formulations and branded products in India. The company provides liquid and lyophilized injections, ophthalmic products, tablets, liquid orals, capsules, softgel capsules, suppositories and ovules, powder for injection, dry syrups, topicals, inhalers, IV infusions, lyophilized products, branded products, dermo cosmetics, and other products. It also operates QueTenX, an e-commerce website. The company was incorporated in 1990 and is headquartered in Chennai, India.

CEO: Sridhar Ganesan3,406 employeesINwww.caplinpoint.net

Top peers ranked by VM Score. Compare valuation, quality, and risk metrics across the sector.

Browse More

Key metrics explained

Definitions, formulas, and how ValueMarkers calculates each indicator used in CAPLIPOINT.NS’s VM Score.

Explore More

Compare Competitors

Weekly Stock Analysis - Free

5 undervalued stocks, fully modeled. Every Monday. No spam.

Cookie Preferences

We use cookies to analyze site usage and improve your experience. You can accept all, reject all, or customize your preferences.